SEC5/EXOC2 is a core component of the exocyst complex, a multiprotein machinery essential for polarized secretion and membrane remodeling. The SEC5 antibody enables researchers to detect and study this protein in diverse experimental models, including human and rodent tissues, and cell lines like HeLa and MDA-MB-231.
Target Protein: Exocyst complex component 2 (SEC5/EXOC2)
Gene Symbol: SEC5
Molecular Weight: 95–104 kDa (observed), 104 kDa (calculated)
The SEC5 antibody is validated for multiple techniques, with optimized dilution ranges and tissue/cell-specific performance.
SEC5 antibodies have been extensively used in studies exploring cellular trafficking and signaling pathways.
| Application | 66011-1-Ig | 12751-1-AP |
|---|---|---|
| WB | 3 publications | 18 publications |
| IHC | 1 publication | 1 publication |
| IF | 4 publications | 7 publications |
| IP | 1 publication | 1 publication |
| KD/KO | 1 publication | 8 publications |
WB: Detects SEC5 in brain, ileum, and HEK-293 cells, with high sensitivity at 1:2500–1:10,000 .
IHC: Effective in human cancer tissues (breast, liver) with antigen retrieval optimization .
IF/ICC: Localizes SEC5 in HeLa and MDA-MB-231 cells, enabling subcellular localization studies .
IP/KD/KO: Used for co-immunoprecipitation and knockout validation to study exocyst complex interactions .
Optimal Dilution: Titrate antibodies in each experimental system (e.g., WB: 1:2500–1:10,000 vs. IHC: 1:200–1:800) .
Antigen Retrieval: For IHC, use TE buffer (pH 9.0) or citrate buffer (pH 6.0) .
Storage: Store at -20°C in PBS with glycerol and sodium azide .
The antibody’s specificity is attributed to its recognition of epitopes in the SEC5 protein. Structural studies highlight the role of specificity-determining residues (SDRs) in the variable regions of the antibody’s paratope, enabling high-affinity binding . This mechanism ensures precise detection of SEC5 in complex biological samples.
SEC-5 is a crucial component of the mammalian exocyst complex, which plays an essential role in the precise targeting of exocytic vesicles to specific docking sites on the plasma membrane. This targeting facilitates the secretion of proteins and other molecules, making SEC-5 vital for maintaining cellular communication and homeostasis. SEC-5 interacts with Ral, a small GTPase, in a GTP-dependent manner, which is crucial for the assembly and function of the exocyst complex . In humans, the SEC-5 gene is located on chromosome 6p25.3, and its dysregulation has been associated with several diseases, making it a significant target for research .
SEC-5 antibodies are versatile tools that can be employed in multiple research applications:
Western Blotting (WB): For detecting and quantifying SEC-5 protein expression levels in cell and tissue lysates
Immunoprecipitation (IP): For isolating SEC-5 and identifying its interaction partners
Immunofluorescence (IF): For visualizing the subcellular localization of SEC-5
Enzyme-linked Immunosorbent Assay (ELISA): For quantitative detection of SEC-5 in complex samples
Each application requires specific optimization strategies to ensure reliable and reproducible results when working with SEC-5 antibodies.
Thorough validation is essential before using a SEC-5 antibody in critical experiments:
Cross-reactivity testing: Verify the antibody detects SEC-5 in your species of interest (mouse, rat, human, etc.)
Application-specific validation: Test the antibody in the specific application (WB, IP, IF, ELISA) you intend to use it for
Positive and negative controls: Use samples known to express or lack SEC-5
Specificity verification: Consider knockdown/knockout experiments to confirm signal specificity
Reproducibility assessment: Ensure consistent results across multiple experiments
This systematic validation approach helps ensure experimental data generated with SEC-5 antibodies is reliable and scientifically sound.
Size Exclusion Chromatography (SEC) is a critical method for analyzing antibody quality. The optimal conditions include:
Column selection: Use columns with appropriate pore size for antibody analysis (typically 300Å for monoclonal antibodies)
Mobile phase optimization: A typical buffer contains PBS with salt concentrations adjusted to minimize secondary interactions
pH considerations: Buffer pH significantly impacts SEC performance; optimal pH range is typically 6.0-7.4 for most antibodies
Flow rate: Maintain consistent flow rates (typically 0.5-1.0 mL/min) for reproducible results
Sample preparation: Filter samples and use consistent concentration ranges to avoid column overloading
For challenging antibodies that show multiple monomeric peaks due to secondary interactions, specialized mobile phase compositions (such as 2X PBS with 100 mM arginine at pH 10.55) may be necessary to obtain accurate aggregate quantification .
Multiple-peak profiles in SEC analysis of antibodies can be addressed through systematic troubleshooting:
Buffer modification: Test different buffering components and concentrations to reduce secondary interactions
Additive screening: Evaluate the addition of:
pH optimization: Adjust pH to modify protein surface charge and minimize column interactions
Column selection: Consider alternative column chemistry if secondary interactions persist
Temperature control: Maintain consistent temperature during analysis to prevent temperature-induced conformational changes
When traditional approaches fail, innovative mobile phases (like the one developed for 10E8 antibody with 2X PBS, 100 mM arginine, pH 10.55) can effectively resolve multiple-peak issues without altering the SEC matrix itself .
SEC-5 antibody characterization and protein aggregation analysis are interconnected research areas:
Quality control: SEC is the standard method for monitoring antibody size variants, including SEC-5 antibody preparations
Aggregate quantification: SEC can clearly separate and quantify aggregates, monomers, and fragments of SEC-5 antibody
Molecular weight determination: SEC coupled with multi-angle laser light scattering (SEC-MALS) provides accurate molecular weight measurements of each peak, confirming identity of SEC-5 antibody and its aggregates
Stability assessment: SEC can monitor changes in SEC-5 antibody aggregation under various stress conditions, informing stability studies
Method validation: For regulatory purposes, SEC methods for SEC-5 antibody analysis should be validated for parameters like linearity, specificity, accuracy, and precision
Understanding and controlling aggregation is critical for maintaining the functionality and specificity of SEC-5 antibodies in research applications.
SEC-5 antibodies enable sophisticated investigations of exocyst biology:
Interaction studies: Use co-immunoprecipitation with SEC-5 antibodies to identify and characterize interaction partners within the exocyst complex
Subcellular localization: Apply immunofluorescence with SEC-5 antibodies to track dynamic changes in exocyst localization during cellular processes
GTPase-dependent interactions: Investigate how Ral-GTP binding affects SEC-5 conformation and function within the exocyst complex
Post-translational modifications: Examine how phosphorylation or other modifications of SEC-5 regulate exocyst assembly
Live-cell imaging: Combine SEC-5 antibody epitope mapping with fluorescent protein tagging strategies to visualize exocyst dynamics
These approaches provide critical insights into fundamental mechanisms of vesicle trafficking and membrane fusion events regulated by the exocyst complex.
SEC-MALS (Size Exclusion Chromatography with Multi-Angle Light Scattering) provides valuable insights into SEC-5 antibody properties:
Sample preparation:
Instrument parameters:
Data analysis:
For SEC-5 antibodies with extra light chains, SEC-MALS can accurately determine the molecular composition (e.g., distinguishing between 2H3L and 2H4L configurations) .
Developing site-specific anti-SEC-5 antibodies presents several technical challenges:
Epitope selection:
Identifying functionally relevant domains within SEC-5
Ensuring selected epitopes are surface-exposed in the native protein
Balancing epitope uniqueness with conservation across experimental species
Antibody production considerations:
Determining optimal immunization strategies (peptide vs. protein)
Screening methods to identify clones recognizing native vs. denatured SEC-5
Validation approaches to confirm domain specificity
Cross-reactivity management:
Addressing homology with other exocyst components
Computational prediction and experimental verification of potential cross-reacting domains
Absorption strategies to remove cross-reactive antibodies
Application optimization:
Different epitopes may perform better in specific applications (WB vs. IP vs. IF)
Buffer conditions may need customization for epitope accessibility
Fixation methods for IF may affect epitope recognition
Research strategies focusing on specific functional domains of SEC-5 must address these challenges to develop high-quality domain-specific antibodies.
Optimizing SEC for antibody stability analysis requires systematic method development:
Stress condition selection:
Method robustness parameters:
Quantitative analysis:
Calculate percentage of monomer, aggregates, and fragments
Monitor retention time shifts as indicators of conformational changes
Establish acceptance criteria for each parameter
Validation requirements:
A well-validated SEC method provides reliable data on how different stress conditions affect antibody stability and aggregation propensity.
Several factors can influence SEC-5 antibody specificity in immunofluorescence:
Fixation methods:
Different fixatives (paraformaldehyde, methanol, glutaraldehyde) preserve different epitopes
Fixation duration and temperature affect epitope accessibility
Cross-linking extent can mask SEC-5 epitopes
Permeabilization considerations:
Detergent selection (Triton X-100, saponin, digitonin) impacts antibody access
Permeabilization duration must be optimized for nuclear vs. cytoplasmic antigens
Over-permeabilization can disrupt cellular architecture
Blocking parameters:
Blocking agent selection (BSA, serum, commercial blockers)
Blocking duration and temperature
Blocking buffer composition (detergents, salts)
Antibody incubation conditions:
Primary antibody dilution (typically 1:100-1:500 for SEC-5)
Incubation temperature and duration
Wash buffer composition and washing protocol stringency
Detection system:
Direct vs. indirect detection methods
Signal amplification strategies for low-abundance SEC-5
Fluorophore selection to avoid autofluorescence interference
Systematic optimization of these parameters ensures specific detection of SEC-5 in immunofluorescence applications.
Emerging SEC technologies offer new possibilities for studying SEC-5 antibody-antigen interactions:
Affinity-SEC approaches:
Immobilizing SEC-5 on SEC matrix for studying binding kinetics
Analyzing antibody-antigen complexes under native conditions
Determining binding stoichiometry in multi-component systems
SEC with advanced detection:
SEC-MS for identifying interaction-induced conformational changes
SEC-HDX (hydrogen-deuterium exchange) for mapping interaction surfaces
SEC-ITC (isothermal titration calorimetry) for thermodynamic characterization
Miniaturized SEC platforms:
Microfluidic SEC for reduced sample consumption
High-throughput SEC screening of interaction conditions
Rapid SEC for real-time interaction kinetics
Computational integration:
Molecular dynamics simulations guided by SEC data
Machine learning prediction of SEC profiles for antibody variants
Integration of multiple SEC datasets for comprehensive interaction models
These advanced approaches will provide deeper insights into the molecular mechanisms of SEC-5 antibody binding and functionality.
SEC-5 antibodies are increasingly valuable for investigating disease-related cellular processes:
Neurodegenerative disorders:
Examining how exocyst dysfunction affects neuronal protein trafficking
Investigating SEC-5 roles in synapse formation and maintenance
Studying SEC-5 in glial cell secretory functions
Cancer biology:
Analyzing SEC-5 in cancer cell migration and invasion
Exploring exocyst-mediated secretion of tumor-promoting factors
Investigating SEC-5 in extracellular vesicle biogenesis and release
Inflammatory conditions:
Studying SEC-5 in immune cell secretory functions
Examining exocyst roles in cytokine release
Investigating SEC-5 in antigen presentation processes
Metabolic disorders:
Analyzing SEC-5 in insulin granule exocytosis
Investigating exocyst dysfunction in type 2 diabetes
Studying SEC-5 in adipocyte metabolism
Infectious diseases:
Examining how pathogens manipulate SEC-5 for cellular invasion
Studying exocyst roles in immune response to infection
Investigating SEC-5 in pathogen clearance mechanisms
These emerging applications highlight the expanding significance of SEC-5 antibodies in biomedical research beyond basic cell biology.